𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of interferon-α therapy on cardiac function in patients with chronic hepatitis B infection

✍ Scribed by Mustafa Kemal Erol; Serpil Erol; Mehmet Koruk; Mustafa Ertek; Engin Bozkurt

Publisher
Springer
Year
2004
Tongue
English
Weight
202 KB
Volume
19
Category
Article
ISSN
0910-8327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term beneficial effect of interfero
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
✍ Shi-Ming Lin; I-Shyan Sheen; Rong-Nan Chien; Chia-Ming Chu; Yun-Fan Liaw 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5

Interferon antibodies may negate the ant
Interferon antibodies may negate the antiviral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infection
✍ Dr. Anna Suk-Fong Lok; Ching-Lung Lai; Elsie Kit-Yee Leung 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

In a randomized controlled trial of recombinant a-2a interferon for chronic hepatitis B, interferon antibodies developed in 21 (39%) of 54 Chinese adults who received IFN. No correlation was observed between sex, age, pretreatment serum ALT level or liver histological findings and the development of

Loss of HBsAg with interferon-α therapy
Loss of HBsAg with interferon-α therapy in chronic hepatitis D virus infection
✍ Johnson Y. N. Lau; Ruth King; Christopher J. Tibbs; Adrian P. Catterall; Heather 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

Eleven patients with chronic hepatitis D virus (HDV) infection who had chronic active hepatitis and HDV antigen on liver biopsy were randomised in a crossover therapeutic trial of interferon-alpha 2b vs. no therapy. Nine patients had a history of intravenous drug use (drug free > 6 months before the

Which patients with chronic hepatitis B
Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors
✍ M. Gary Brook; Peter Karayiannis; Howard C. Thomas 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 1 views

Twenty-one pretreatment variables were assessed for their significance in response prediction using data from 114 patients given a-interferon for chronic hepatitis B virus infection. In those patients who had received a minimum of 90 million units per m2 total dose over 12 weeks, a negative anti-hum